Observational Post-authorization Prospective Study to Characterize the Incidence of Epidermal Growth Factor Receptor (EGFR) Mutation Positive and Advanced Non-small Cell Lung Cancer Patients and Their Clinical Management in Galicia
Observational
Observational Model: Cohort, Time Perspective: Prospective
Number of patients with epidermal growth factor receptor (EGFR) positive mutation among advanced or metastatic non-small-cell lung cancer (NSCLC) patients in Galicia
10 months (recruitment period)
No
Sergio Vázquez Estévez, Doctor
Study Director
Grupo Gallego de Cáncer de Pulmón (GGCP)
Spain: Agencia Española de Medicamentos y Productos Sanitarios
GGCP 048-10
NCT01717105
March 2011
February 2013
Name | Location |
---|